双侧丘脑中央中核脑深部电刺激治疗儿童Lennox-Gastaut综合征:单中心经验
本研究回顾性分析2020至2021年由单一术者实施的6例(4女2男,6-19岁)Lennox-Gastaut综合征患儿接受双侧丘脑中央中核脑深部电刺激的临床与癫痫结局。术后平均随访16.3个月,4例癫痫发作频率减少>60%,1例减少10%,1例无变化,无患儿出现植入相关不良神经效应。作者认为该疗法安全有效,可作为替代或辅助治疗,但需更大样本研究。
要点
- 6例LGS患儿接受双侧CMTN DBS,术后平均随访16.3个月。
- 4例发作频率减少>60%,1例减少10%,1例无变化,无恶化。
- 无植入相关不良神经效应,术后平均住院2天。
核心结论
- 作者认为CMTN DBS是安全有效的治疗方式,可考虑作为LGS难治性癫痫患儿的替代或辅助治疗。
- 作者指出需进一步开展更大样本研究。
研究设计与样本
- 经机构审查委员会批准的回顾性分析,纳入2020至2021年由单一术者行双侧CMTN DBS的≤19岁临床诊断LGS患者。
- 共纳入4例女性和2例男性,年龄6-19岁。
主要发现
- 术前每例患儿均有至少6年难治性癫痫史,其中4例自婴儿期起病。
- 5例既往植入迷走神经刺激器,2例既往行胼胝体切开术。
- DBS术后平均住院时间为2天,无患儿出现植入相关不良神经效应,平均随访16.3个月。
- 4例术后癫痫发作频率减少>60%,1例减少10%,1例无变化,无患儿报告发作症状加重。
临床怎么用
- 作者认为CMTN DBS可考虑作为该类难治性癫痫患儿的替代或辅助治疗。
局限性
- 原文指出相关文献稀少。
- 原文指出需进一步开展更大样本研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical management of pediatric patients with nonlesional, drug-resistant epilepsy, including patients with Lennox-Gastaut syndrome (LGS), remains a challenge given the lack of resective targets in most patients and shows seizure freedom rates <50% at 5 years. The efficacy of deep brain stimulation (DBS) is less certain in children than in adults. This study examined clinical and seizure outcomes for pediatric patients with LGS undergoing DBS targeting of the centromedian thalamic nuclei (CMTN). METHODS: An institutional review board-approved retrospective analysis was performed of patients aged ≤19 years with clinical diagnosis of LGS undergoing bilateral DBS placement to the CMTN from 2020 to 2021 by a single surgeon. RESULTS: Four females and 2 males aged 6-19 years were identified. Before surgery, each child experienced at least 6 years of refractory seizures; 4 children had experienced seizures since infancy. All took antiseizure medications at the time of surgery. Five children had previous placement of a vagus nerve stimulator and 2 had a previous corpus callosotomy. The mean length of stay after DBS was 2 days. No children experienced adverse neurologic effects from implantation; the mean follow-up time was 16.3 months. Four patients had >60% reduction in seizure frequency after surgery, 1 patient experienced 10% reduction, and 1 patient showed no change. No children reported worsening seizure symptoms after surgery. CONCLUSIONS: Our study contributes to the sparse literature describing CMTN DBS for children with drug-resistant epilepsy from LGS. Our results suggest that CMTN DBS is a safe and effective therapeutic modality that should be considered as an alternative or adjuvant therapy for this challenging patient population. Further studies with larger patient populations are warranted.
引用
- Bonda D, Kelly KA, Boop S, et al. Deep Brain Stimulation of Bilateral Centromedian Thalamic Nuclei in Pediatric Patients with Lennox-Gastaut Syndrome: An Institutional Experience. World Neurosurg. 2024. PMID: 38403017. doi:10.1016/j.wneu.2024.02.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。